NCT01627262View on ClinicalTrials.gov

Mesalamine for Uncomplicated Diverticular Disease: a Randomized, Double-blind, Placebo-controlled Study

PHASE2CompletedINTERVENTIONAL
Enrollment

123

Participants

Timeline

Start Date

May 31, 2002

Primary Completion Date

August 31, 2004

Study Completion Date

April 30, 2006

Conditions
Colonic Diverticulosis
Interventions
DRUG

Mesalamine

3x1000mg mesalamine granules per day

DRUG

Placebo

3x1000mg placebo granules per day

Trial Locations (1)

51103

Ev. Krankenhaus Kalk, University of Cologne, Cologne

Sponsors
All Listed Sponsors
lead

Dr. Falk Pharma GmbH

INDUSTRY